News

ADC Therapeutics to Participate in Major Healthcare Conference

ADC Therapeutics to Participate in Major Healthcare Conference

ADC Therapeutics Announces Upcoming Conference Participation

ADC Therapeutics SA (NYSE: ADCT), a trailblazer in the development of antibody drug conjugates, is gearing up to share its insights and innovations at an upcoming major healthcare conference. Ameet Mallik, the Chief Executive Officer, will engage in a fascinating fireside chat during the Cantor Global Healthcare Conference, set to take place soon. The discussion promises to provide valuable updates on the company’s cutting-edge therapies and strategic initiatives.

Webcast Access for the Presentation

For those interested in the insights shared during the conference, a live webcast will be accessible through the Investors section of ADC Therapeutics' official website. Attendees can look forward to a replay being available for around 30 days after the event, allowing ample opportunity to gain perspective on ADC Therapeutics’ exciting developments.

Innovative Products Transforming Patient Care

ADC Therapeutics is on the forefront of revolutionizing cancer treatment with its promising portfolio, including ZYNLONTA (loncastuximab tesirine-lpyl). This product has already earned accelerated approval for treating relapsed or refractory diffuse large B-cell lymphoma, marking a significant milestone in addressing a critical need within oncology. Efforts are ongoing to explore additional therapies and combinations to enhance patient outcomes at earlier stages of treatment.

Future Developments in Antibody Drug Conjugates

The company is not resting on its laurels. Alongside ZYNLONTA, ADC Therapeutics is harnessing its expertise to propel the development of an innovative PSMA-targeting ADC, utilizing a distinctive exatecan-based payload designed to maximize treatment efficacy. This underscores the company’s commitment to pioneering advancements in the ADC field.

A Dedicated Approach to ADC Development

Headquartered in Lausanne, Switzerland, with additional operations in major cities, ADC Therapeutics is steadfast in its mission to drive innovation in antibody drug conjugates from clinical development right through to commercialization. The added ability to seamlessly integrate these processes allows for robust advancements in the treatment landscape for patients battling cancer.

Company Contact Information

For inquiries, ADC Therapeutics encourages interested parties to reach out for further information regarding their products, research initiatives, or future opportunities. While specific email contacts are not included, ADC Therapeutics maintains an accessible communication line for both investors and media inquiries.

Frequently Asked Questions

What is ADC Therapeutics known for?

ADC Therapeutics is recognized as a leader in the development of antibody drug conjugates, providing innovative therapies for cancer treatment.

When will ADC Therapeutics present at the conference?

Ameet Mallik, the CEO of ADC Therapeutics, will present at the Cantor Global Healthcare Conference in the coming days.

What is ZYNLONTA?

ZYNLONTA (loncastuximab tesirine-lpyl) is a product developed by ADC Therapeutics approved for treating certain types of lymphoma.

How can I access the webcast?

The webcast for the presentation can be viewed on the Investors section of ADC Therapeutics' official website.

Where is ADC Therapeutics headquartered?

ADC Therapeutics is headquartered in Lausanne, Switzerland, with operational branches in multiple locations, including London and New Jersey.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

AbbVie's Bold Leap in Menstrual Migraine Treatment

Updated Category News Views 9

AbbVie's Game-Changing Atogepant Study When it comes to pushing boundaries in the pharmaceutical world, there's no sitting on the fence. AbbVie's Phase 3 LUNA study results are painting a bright picture for women who suffer from the relentless grip of menstrual migraines. In a world where not a single treatment option has been approved specifically for this condition,...

Continue Reading
Step Inside Henson's Creature Shop Magic in NYC

Updated Category News Views 0

Unlock Puppet Magic with Jim Henson Tours Puppet fans, let me tell you, there's something going on in Queens, NY that's got both nostalgia and innovation scribbled all over it. We're talking about the legendary Jim Henson's Creature Shop opening its doors. If you're looking to relive the magic that helped shape a generation, get ready to dive into a world where creativity...

Continue Reading
Diaper Affordability: A Hidden Crisis, Taxpayer Burden

Updated Category News Views 6

A Silent Crisis Lurking in Diapers Diapers. We don’t think about them much until we need them, but nearly half of U.S. families are painfully aware of their cost. According to a report from the NDBN Diaper Check 2026, many struggle to meet this basic necessity. This isn't just about keeping babies clean—it's a public health issue with economic ripples Congress can't...

Continue Reading
Bitwise Pulls Plug on Dogecoin ETF Amid Market Risks

Updated Category News Views 3

Bitwise Ditches Dogecoin ETF: End of a Speculative Era Who knew that a digital asset inspired by an internet meme would get a platform on Wall Street? Well, Bitwise did. They rallied behind Dogecoin, launching the Bitwise Dogecoin ETF, ticker BWOW. But as of September 10, 2026, the fund's journey is coming to an end with liquidation just around the corner. What Sparked...

Continue Reading
Red-Eye Flights Surge, Driven By Western U.S. Routes

Updated Category News Views 3

You can always count on some things staying the same, right? Well, if you thought red-eye flights were going to fade away, think again. These late-night wonders are not just hanging around—they're booming in the west like there's no tomorrow. Literally. Champion Traveler has laid it all out for us: about 115,580 overnight flights in 2025, a record high since this mad...

Continue Reading
Helio Fred Garcia Honored by Diversity Action Alliance

Updated Category News Views 4

Award Ceremony Set in the Big Apple In an industry where recognition often feels as transient as a ticker's daily high, the Diversity Action Alliance (DAA) is doing its bit to emphasize the lasting impact individuals can make. On September 16 in New York City, Helio Fred Garcia will be honored with the 2026 Pat Ford Larger Than Life Impact Award at the DAA's Annual...

Continue Reading
Cannabis Industry Pushes for Robust Financial Services

Updated Category News Views 3

Industry Gears Up for Financial Action Clearly, cannabis businesses are shouting louder than a vendor at a ballgame, demanding more than just the basic chips-and-soda banking service. They’re on the hunt for serious credit facilities, payments, and the traditional financial tools that most sectors take for granted. I mean, check this out: Shield Compliance just dropped...

Continue Reading
BusyBee AI Revolutionizes Classroom Feedback Efficiency

Updated Category News Views 1

Grading Overhaul: BusyBee's Role in Education Here's a twist for the history books: Agilix Labs' BusyBee, a slick AI assistant built right into the Buzz platform on Amazon Bedrock, is kicking traditional grading methods to the curb. This little helper is grading close to a million K-12 student submissions every month, meticulously approved by real teachers. Quite the...

Continue Reading
Unpacking RAGEism: Power Dynamics in U.S. Policies

Updated Category News Views 3

Seeing Patterns in Crisis: Jackson and Flint When Jackson, Mississippi's latest water crisis hit the news, it wasn't the first time folks were left high and dry. No, this fiasco's got deep roots, and it resonates with another infamous case: Flint, Michigan. In Maya Rockeymoore Cummings' book, RAGEism, these are badge-worthy examples of 'Resource Hoarding' where government...

Continue Reading
World Fire Congress 2026 Champions Global Fire Safety

Updated Category News Views 1

Rethinking Fire Safety with a Global Mindset The 2026 World Fire Congress wrapped up in London, signaling a big shift in how we tackle fire safety. Over 60 nations were represented, and they all walked away singing the same tune: if we’re going to handle these ever-mounting fire risks, we have to lean on each other a lot more. Next stop on this crusade? The flashy city...

Continue Reading

Top 5 Most Recently Viewed Articles

Municipality Finance Removes EUR 20 Million Notes from Trading

Updated Category News Views 167

Exciting Developments at Municipality Finance Municipality Finance Plc has recently made headlines with the redemption of its EUR 20 million notes. This significant event is a big step in the financial landscape, particularly for investors watching the activities around Nasdaq Helsinki. Redemption of Notes On a notable day, Municipality Finance publicly announced its...

Continue Reading
ONEOK's Upcoming Participation in Investor Conference

Updated Category News Views 153

ONEOK's Participation in an Upcoming Investor Conference ONEOK, Inc. (NYSE: OKE) is set to engage in an investor conference this week, featuring a fireside chat session scheduled for 1:10 p.m. Eastern Time on Wednesday. This event reflects ONEOK's commitment to transparency and stakeholder engagement, highlighting its role in the energy sector. Webcast Availability This...

Continue Reading
Transforming Cancer Treatment: How GT Biopharma Innovates Health

Updated Category News Views 112

The Shift Towards Platform-Based Biologics in Cancer Treatment The precision medicine sector is experiencing a significant transformation, moving from traditional methods to a platform-based approach for developing biologics. This evolution is expected to expand the market from its current valuation to over $537 billion by 2035. Investors are beginning to favor modular...

Continue Reading
The Future of ESG Investing in 2024 and Beyond

Updated Category Investing Views 310

In an era defined by rapid technological advancements and a heightened collective consciousness towards social and environmental issues, ESG (Environmental, Social, Governance) investing has transcended from niche to necessity. Investors, financial advisors, and sustainability enthusiasts alike are increasingly aligning their portfolios with their principles, reshaping...

Continue Reading
Autism Therapy Demand Soars in Raleigh Amid Rapid Growth

Updated Category News Views 167

Raleigh's Growth and the Surge in Autism Services Demand As populations in various communities grow, the need for essential health services, including autism therapy, becomes paramount. Raleigh stands out in this trend as an area that continues to expand rapidly, prompting families to seek high-quality autism therapy resources for their children. The increasing population...

Continue Reading